Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30, 2026.

November 02, 2026 BSE Limited National Stock Exchange of India Ltd., Department of Corporate Relationship Department of Corporate Services 1st Floor, New Trade Ring, Rotunda Building Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers C-1, Block G,Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (E),Mumbai – 400 051 Scrip Code: 524742 Scrip Code: CAPLIPOINT. Dear Sir/Madam, Sub: Board meeting intimation This is to inform that a meeting of the Board of Directors of the Company will be held on Thursday, November 12, 2026, to consider and approve, inter-alia, the unaudited financial results of the Company for the quarter and half-year ended September 30, 2026 (both standalone & consolidated); This intimation is being given in compliance with the provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. As informed earlier vide our letter dated September 28, 2026, the trading window for dealing in the Company’s scrips by the Designated Persons and their immediate relatives will remain closed from October 01, 2026 till November 14, 2026 (both days inclusive), in terms of the Company’s Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015. Kindly take the same on your records. Sincerely Yours For Caplin Point Laboratories Limited Venkatram G General Counsel & Company Secretary Membership No A23989